July 20, 2017
Kowa President & CEO Yoshihiro Miwa Kowa President & CEO Yoshihiro Miwa is looking to grow the company’s new hyperlipidemia treatment Parmodia (pemafibrate), a successor to its statin star Livalo (pitavastatin), into a big seller that would eventually rake in...read more